<DOC>
	<DOCNO>NCT00496184</DOCNO>
	<brief_summary>To evaluate use topical application Nifedipine cream treatment Provoked localize Vulvodynia ( vestibulitis , vestibulodynia ) .</brief_summary>
	<brief_title>Efficacy Study Topical Application Nifedipine Cream Treat Vulvar Vestibulitis</brief_title>
	<detailed_description>30 woman age 18-45 diagnose Provoked localize Vulvodynia include . 10 woman use topical Nifedipine cream 0.2 % 4 time day 6 week ( except menstrual period ) . 10 woman use topical Nifedipine cream 0.4 % 4 time day 6 week ( except menstrual period ) . 10 woman control group use placebo cream . The study randomize double blind . Participants examine start treatment , end treatment 3 month completion treatment . A special detailed questionnaire prepare three language use compare dyspareunia associate variable group . The Q-tip test perform finding draw examination . Differences group examine , uni- multi-variate analysis perform .</detailed_description>
	<mesh_term>Vulvodynia</mesh_term>
	<mesh_term>Vulvar Vestibulitis</mesh_term>
	<mesh_term>Vulvar Diseases</mesh_term>
	<mesh_term>Nifedipine</mesh_term>
	<criteria>1 . Women diagnose vestibulitis accord Friedrich 's criterion : Severe pain vestibular touch attempt vaginal entry . A positive Qtip test : pain produce touching vestibule cotton tip applicator . Physical finding limit vary degree vestibular erythema . 2 . Nonpregnant woman age 1845 . 3 . Women use effective contraception interested become pregnant study period . 4 . No known Nifedipine allergy . 5 . No medical disease . 1 . Women undergone vestibulectomy . 2 . Active vaginal pelvic infection . 3 . A medical disease uch Diabetes , immune suppression .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>May 2008</verification_date>
	<keyword>Nifedipine treatment</keyword>
	<keyword>Vestibulitis</keyword>
	<keyword>Placebo</keyword>
</DOC>